Science · Open for opinions
Will the Phase I clinical trial of the Vivaxin malaria vaccine begin dosing in volunteers by November 30, 2026?
Consider the start of human dosing between 10/11 and 30/11 following regulatory approval granted by Anvisa. 79 opinions, 65% Yes
- Yes — 65%
- No — 35%
Deadline: November 30, 2026 at 11:59 PM UTC · 79 opinions
Resolution rules
Consider the start of human dosing between 10/11 and 30/11 following regulatory approval granted by Anvisa.
Source: agenciabrasil.ebc.com.br
Frequently asked questions about this event
How is this event resolved?
Janela de apuração: de 11/10/2026 (00:00, horário de Brasília) até 30/11/2026 (23:59). Fatos, anúncios ou eventos anteriores ao início da janela não contam. Resolve como 'Sim' se o CTVacinas/UFMG, o Ministério da Saúde ou a Anvisa confirmarem publicamente o início da dosagem/aplicação nos 48 voluntários da Fase I até 30/11/2026. Caso contrário, resolve como 'Não'.
How are points scored?
Points depend on the share of votes your side had when you gave your opinion. Being right earns 100 minus that share. Being wrong costs that share.
Right now Yes has 65% of the votes: an opinion on it that turns out right earns about 35 points, a wrong one costs about 65.